Shop high-purity Tesamorelin 10mg at Eternal Peptides, the preferred source for verified research compounds in the USA. This synthetic GHRH analogue is synthesized to a standard of ≥99% purity, with every batch rigorously tested and certified by Janoshik Analytical. Order today for fast, discreet US shipping and free Priority delivery on orders over $200.
Tesamorelin Peptide Properties
Property Description Name Tesamorelin (synthetic analogue of human growth hormone–releasing hormone, GHRH 1–29); N-acetylated peptide with a D-amino acid substitution to enhance stability Sequence Ac-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 Molecular Weight ~5135 Da (minor variation may occur) Form Lyophilized peptide in glass vials Purity ≥99%, verified with COAs Solubility Soluble in sterile water or appropriate aqueous laboratory buffers
Batch: EP-250522-TE10
Handling & Storage Guidelines
Upon receiving your Tesamorelin order, store the vials of lyophilized powder at –4°F to 14°F (–20°C to –10°C) and keep it protected from light and moisture to preserve peptide stability. Avoid prolonged exposure to ambient humidity during handling.
For laboratory use, reconstitute the powder using sterile/bacteriostatic water or an appropriate laboratory-grade aqueous solvent, following recommended operating procedures. Add the bacteriostatic water gently down the vial wall and allow the peptide to dissolve naturally; avoid vigorous shaking or agitation, which may promote degradation.
For best results, buy bacteriostatic water with your Tesamorelin here at Eternal Peptides for assured purity and quality.
Once reconstituted, it is recommended to aliquot the solution into sterile containers to minimize repeated freeze–thaw cycles. Repeated freezing and thawing can negatively affect peptide integrity and reproducibility.
Reconstituted working solutions may be stored at 36°F to 46°F (2°C to 8°C) for short-term use (several days) or at –112°F to –94°F (–80°C to –70°C) for longer-term storage, depending on study duration and laboratory protocol.
All handling should be conducted using appropriate laboratory safety practices, sterile technique, and in compliance with institutional biosafety guidelines and research-use regulations.
COA / Quality Assurance
Eternal Peptides provides a Certificate of Analysis (COA) for every Tesamorelin product lot to support transparency, traceability, and confidence in research reproducibility. Each COA is lot-specific and corresponds directly to the unique batch identifier assigned to the vial, allowing precise verification during audits or experimental documentation.
COAs typically include peptide identity confirmation using analytical methods, such as high-performance liquid chromatography (HPLC), mass spectrometry, and other quantitative purity tests to verify at least 99% purity.
Where applicable, reports also include sterility assessments, endotoxin level analysis, and recommended storage conditions to ensure proper handling throughout the research lifecycle.
All analytical testing is conducted through independent third-party labs, including established providers such as Janoshik, to ensure objective and industry-standard evaluation. COAs are publicly accessible through the Eternal Peptides Lab Tests page.
Legal / Regulatory Disclaimer
Eternal Peptides supplies Tesamorelin for laboratory research use only. It is not approved for human or veterinary use and is not intended for clinical administration, therapeutic intervention, diagnostic procedures, or consumption of any kind.
The safety, efficacy, and long-term effects of Tesamorelin in humans have not been established, and all data referenced are derived from research settings.
As the purchaser and user, you are solely responsible for ensuring compliance with applicable local, state, and federal laws, institutional biosafety requirements, and research-use regulations governing the handling and use of research peptides.
Misrepresentation of intended use, including diversion for non-research purposes, may result in regulatory action or legal consequences.